Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Barrett Epithelium

fluorodeoxyglucose f18 has been researched along with Barrett Epithelium in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, HM; Lee, YC; Lin, JT; Tseng, PH; Tu, CH; Wang, HP; Wang, SY; Wu, MS; Wu, YW; Yang, WS1
Bradshaw, L; Farukhi, I; Gould-Simon, A; Kaif, M; Lazaga, F; Schmidt, R; Stagg, J; Thompson, C1
Lenglinger, J; Riegler, M; Ringhofer, C1
Feith, M; Siewert, JR; Stein, HJ1
Grünwald, F; Junginger, T; Kneist, W; Menzel, C1
Herts, BR; Remer, EM; Yoon, JK1
Becker, K; Fink, U; Lordick, F; Ott, K; Peschel, C; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA1
Alia, AG; Amin, T; Bakheet, SM; Kuzo, R; Powe, J1
Alavi, A; Ghesani, N; Neto, CA; Zhuang, H1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Barrett Epithelium

ArticleYear
[Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett's cancer].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2009, Volume: 80, Issue:11

    Topics: Adenocarcinoma; Barrett Esophagus; Blood Glucose; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis

2009

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Barrett Epithelium

ArticleYear
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Adipose Tissue; Adult; Barrett Esophagus; Body Mass Index; Duodenum; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Obesity; Positron-Emission Tomography; Severity of Illness Index; Stomach; Surveys and Questionnaires; Waist Circumference

2014
Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Barrett Esophagus; Diagnosis, Differential; Endoscopy, Digestive System; Esophageal Diseases; Esophageal Neoplasms; Esophagitis; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; United States; United States Department of Veterans Affairs

2015
AEG I and II: is it one tumor entity?
    Annals of surgery, 2008, Volume: 247, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome

2008
[Barrett-adenocarcinoma of the esophagus: false negative finding in a surgeon using FDG-PET].
    Nuklearmedizin. Nuclear medicine, 2002, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Adult; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed

2002
Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss.
    AJR. American journal of roentgenology, 2006, Volume: 187, Issue:5

    Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Barrett Esophagus; Contrast Media; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2006
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
    Annals of surgery, 2007, Volume: 246, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome

2007
F-18 FDG uptake in benign esophageal disease.
    Clinical nuclear medicine, 1999, Volume: 24, Issue:12

    Topics: Adult; Aged; Barrett Esophagus; Diagnosis, Differential; Esophageal Diseases; Esophageal Neoplasms; Esophageal Spasm, Diffuse; Esophageal Stenosis; Esophagitis; Female; Fluorodeoxyglucose F18; Gastroesophageal Reflux; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed

1999
Detection of Barrett's esophagus superimposed by esophageal cancer by FDG positron emission tomography.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:12

    Topics: Adenocarcinoma; Barrett Esophagus; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed

2001